Ormeloxifene (Centchroman) is a selective estrogen receptor modulator (SERM) primarily used as an oral contraceptive and for the treatment of dysfunctional uterine bleeding. By acting on estrogen receptors,… Read more
Ormeloxifene (Centchroman) is a selective estrogen receptor modulator (SERM) primarily used as an oral contraceptive and for the treatment of dysfunctional uterine bleeding. By acting on estrogen receptors, it inhibits endometrial receptivity to blastocyst signals without interfering with the hypothalamo-pituitary-ovarian axis. This category contains a range of high-quality analytical standards, including impurities, metabolites, and stable isotope-labelled compounds essential for pharmaceutical research and development. These reference materials are critical for laboratories performing impurity profiling, method validation, and rigorous quality control of ormeloxifene-based formulations. Researchers rely on these authenticated compounds to ensure accurate identification and quantification during routine stability testing and pharmacokinetics studies. By utilizing these precise reference standards, analytical chemists can maintain compliance with regulatory requirements and confirm the safety and efficacy of the parent drug in diverse pharmaceutical applications.